Life sciences firm ScubaTx opens Manchester base after £1.5m funding round to develop its organ transplant technology
A life sciences company looking to “revolutionise” technology around organ transplantation has raised another £1.4m and has opened a base in Manchester.
ScubaTx has raised £1.4m, in a round led by the Praetura Ventures-managed GMC Life Sciences Fund By Praetura, to continue developing its organ preservation device.
It follows a sustained period of growth for the Newcastle University spinout, which enjoyed a successful £1.5m funding round last year.
ScubaTx was founded by CSO Dr William (Bill) Scott and is led by CEO David Campbell. It uses a process called ‘persufflation’ to cool donated organs and oxygenate tissues with humidified gas at tightly controlled pressures and flow rates. That keeps a donated organ viable for “significantly longer”.
The company now has 12 people at its new office at Manchester Science Park, including six new hires. These staff will focus on “building capabilities across operational, quality assurance and regulatory affairs, mechanical, electrical and software engineering”.
ScubaTx says the office will help it
